The Challenges of Antitubercular Drug Discovery
Carregando...
Arquivos
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Capítulo de livro
Direito de acesso
Arquivos
Fontes externas
Fontes externas
Resumo
Although extensive efforts have been undertaken to eradicate tuberculosis (TB), it remains one of the deadliest infections. The rising number of drug-resistant strainsStraindrug-resistant contributing to high mortalityMortality rates has become a global concern, highlighting the need for suitable treatments to eliminate such strains. However, the limitations of current therapies are long treatment duration, adverse side effectsSide effect, interactions with other drugs, toxicity, and poor efficacyEfficacy against latent strains. Thus, the search for safe and effective anti-TB drugsDruganti-TB is urgent. This chapter addresses the advances and challengesChallenge in drug discoveryDiscoverydrug for treating TB by focusing on the recently approved drugsDrugApproved and the most promising candidatesCandidate that can contribute to current therapies. Antitubercular drug discovery: challenges
Descrição
Palavras-chave
Antitubercular drugs, Drug design, Mycobacterium tuberculosis, New drugs, Tuberculosis
Idioma
Inglês
Citação
Integrated Science, v. 11, p. 483-498.
